Systemic autoinflammatory disease following COVID-19 mRNA vaccine: a severe and rare clinical presentation

Case 1A 48-year-old woman, without relevant medical records, was referred to our Internal Medicine Unit for persistent elevated fever (over 38.5 C) that had lasted for about 1 month and started the day after she had received the second shot of COVID-19 mRNA vaccine.Upon admission, the patient denied accompanying symptoms and, at physical examination, no significant pathological signs were detected.Blood tests showed only increased C-reactive protein (CRP) levels (Table 1).In the differential diagnostic process, we indeed considered an infective, malignant and/or autoimmune etiology of her febrile status.Multiple blood and urine cultures were performed that resulted sterile as negative for procalcitonin, along with the serology for viruses and autoimmune pattern tests.Total body scan and bone marrow biopsy did not show any pathological signs.She was successfully treated with prednisone 25 mg die ex-juvantibus.After 4 months, she experienced fever relapse during decalage of steroid therapy.

Authors

Institutions

Publication Details

Journal
Internal and Emergency Medicine
Published
2025-05-15
DOI
https://doi.org/10.1007/s11739-025-03965-9
Primary Topic
Dermatological and COVID-19 studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Systemic autoinflammatory disease following COVID-19 mRNA vaccine: a severe and rare clinical presentation

Jacopo Croce, Elisa Tinazzi, Simonetta Friso, Federica Maiolini et al.
Internal and Emergency Medicine
Dermatological and COVID-19 studies
article

Systemic autoinflammatory disease following COVID-19 mRNA vaccine: a severe and rare clinical presentation

Jacopo Croce, Elisa Tinazzi, Simonetta Friso, Federica Maiolini, Eleonora Bassanello
article en

Abstract

Case 1A 48-year-old woman, without relevant medical records, was referred to our Internal Medicine Unit for persistent elevated fever (over 38.5 C) that had lasted for about 1 month and started the day after she had received the second shot of COVID-19 mRNA vaccine.Upon admission, the patient denied accompanying symptoms and, at physical examination, no significant pathological signs were detected.Blood tests showed only increased C-reactive protein (CRP) levels (Table 1).In the differential diagnostic process, we indeed considered an infective, malignant and/or autoimmune etiology of her febrile status.Multiple blood and urine cultures were performed that resulted sterile as negative for procalcitonin, along with the serology for viruses and autoimmune pattern tests.Total body scan and bone marrow biopsy did not show any pathological signs.She was successfully treated with prednisone 25 mg die ex-juvantibus.After 4 months, she experienced fever relapse during decalage of steroid therapy.

Internal and Emergency MedicineVol. 20(8)
University of Verona (IT)
Università degli Studi di Verona
Zero hunger
Openalex Percentile: Top 80%
Dermatological and COVID-19 studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.